^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    pan-CLK inhibitor

    Related drugs:
    Apply
    A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors (NCT05084859)
    Phase 1b
    Biosplice Therapeutics, Inc.
    Active, not recruiting
    Last update posted :
    10/20/2022
    Initiation :
    11/03/2021
    Primary completion :
    07/01/2024
    Completion :
    07/01/2026
    ALK • NTRK
    |
    EGFR mutation
    |
    docetaxel • 5-fluorouracil • Vectibix (panitumumab) • abiraterone acetate • irinotecan • prednisone • leucovorin calcium • cirtuvivint (SM08502)